| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$3 |
June 2025 Quarterly Activity Report and Appendix 4C
|
30 Jul 2025 9:45AM |
$0.175 |
$0.012 |
fallen by
93.14%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Cynata Therapeutics Limited provided a Quarterly Activity Report for June 2025.
- Ongoing progress of Cymerus™ MSC technology in clinical trials, especially Phase 3 osteoarthritis study.
- Stable financial position and details regarding operating cash flows for the reported quarter.
- Continued patient recruitment and trial advancements for regenerative medicine products.
- Engagement with regulatory authorities and updates on partnership discussions.
- Emphasis on commercialisation strategies and next steps in development pipeline.
- Focus on maintaining momentum in clinical programs and achieving planned milestones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$8 |
1AD Investor Presentation
|
30 Jul 2025 9:45AM |
$0.002 |
$0.003 |
risen by
50%
|
|
| Sequoia Financial Group Ltd (SEQ) ORDINARY FULLY PAID |
Financials |
$13 |
Response to ASX Price Query
|
30 Jul 2025 9:45AM |
$0.240 |
$0.110 |
fallen by
54.17%
|
|
SEQ - Price-sensitive ASX Announcement
Full Release
Key Points
- SEQ received a price and volume query from the ASX regarding unusual trading activity.
- The company confirmed it is not aware of any unannounced information that could explain the change.
- There are no pending or undisclosed matters requiring announcement under ASX Listing Rule 3.1.
- SEQ asserts that it is in compliance with its continuous disclosure obligations.
- The company secretary formally responded to the ASX to clarify the situation.
- SEQ assured the ASX and market participants of its transparency and adherence to regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,506 |
Retirement of Director
|
30 Jul 2025 9:45AM |
$18.180 |
$22.670 |
risen by
24.70%
|
|
| Nido Education Limited (NDO) ORDINARY FULLY PAID |
Consumer Discretionary |
$79 |
2025 Half Year Results Investor Briefing and buy-back update
|
30 Jul 2025 9:44AM |
$0.670 |
$0.350 |
fallen by
47.76%
|
|
| CurveBeam AI Limited (CVB) ORDINARY FULLY PAID |
Health Care |
$13 |
Investor Presentation - Q4 FY25 Quarterly Update
|
30 Jul 2025 9:44AM |
$0.078 |
$0.027 |
fallen by
65.38%
|
|
CVB - Price-sensitive ASX Announcement
Full Release
Key Points
- CurveBeam AI Limited delivered its Q4 FY25 Investor Presentation on May 8, 2024.
- The company specializes in AI-powered orthopedic imaging solutions.
- Highlights include successful product developments, clinical research milestones, and leadership team expansion.
- The company expanded its commercial footprint in the U.S. and Europe.
- Financial results reflect revenue growth, margin improvement, and positive operating trends.
- Several AI-enabled product launches are in the pipeline, supported by clinical and regulatory progress.
- Ongoing focus on innovation and market leadership in musculoskeletal health imaging.
- Strategic priorities include continued U.S. expansion, operational efficiency, and leveraging AI to address clinical needs.
- Strong commitment to clinical validation and regulatory compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$161 |
Change in substantial holding
|
30 Jul 2025 9:43AM |
$0.910 |
$0.410 |
fallen by
54.95%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$3 |
Refinancing of Corporate Funding Arrangements
|
30 Jul 2025 9:42AM |
$0.006 |
$0.003 |
fallen by
50%
|
|
ID8 - Price-sensitive ASX Announcement
Full Release
Key Points
- identitii Limited has refinanced its existing corporate funding arrangements.
- The previous facility with PURE Asset Management has been replaced.
- A new secured lending facility was entered with Mercer Street Global Opportunity Fund, LLC.
- The new arrangement offers improved terms and greater funding flexibility.
- The refinancing extends the maturity profile of identitii’s debt.
- Previous financial covenants have been removed under the new facility.
- The refinancing strengthens identitii’s balance sheet.
- The arrangement supports identitii’s strategic focus on product commercialisation and market expansion.
- The company believes the new funding aligns better with its long-term growth initiatives.
- The announcement was made on June 5, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,506 |
ALS AGM 2025 CEO Address
|
30 Jul 2025 9:42AM |
$18.180 |
$22.670 |
risen by
24.70%
|
|
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Company Update and Appointment of Voluntary Administrators
|
30 Jul 2025 9:41AM |
$0.075 |
$0.075 |
fallen by
0%
|
|
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$64 |
June 2025 Quarterly Update and Appendix 4C
|
30 Jul 2025 9:41AM |
$0.045 |
$0.061 |
risen by
35.56%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics Limited advanced clinical trials for PTX-100 and PTX-200 cancer therapies.
- Positive interim data reported from ongoing clinical trials.
- Progress achieved in the development and expansion of the OmniCAR and CellPryme platforms.
- Significant investment in research and development activities during the quarter.
- The company maintained a healthy cash balance to support its planned operations.
- Updates provided on collaborations, preclinical studies, and manufacturing activities.
- The company remains focused on the development of next-generation cancer therapies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$19 |
Investor Update Q3
|
30 Jul 2025 9:40AM |
$0.005 |
$1.620 |
risen by
32,300%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$175 |
Update - Notification of buy-back - CEH
|
30 Jul 2025 9:40AM |
$0.370 |
$0.450 |
risen by
21.62%
|
|
| Kalamazoo Resources Limited (KZR) ORDINARY FULLY PAID |
Materials |
$41 |
Investor Presentation
|
30 Jul 2025 9:40AM |
$0.090 |
$0.130 |
risen by
44.44%
|
|
| Westar Resources Limited (WSR) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities Report
|
30 Jul 2025 9:39AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
WSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed drilling programs at Pilbara and Southern Cross gold and lithium projects
- Preliminary assay results indicate promising mineralization
- Ongoing geological mapping and targeting of new exploration areas
- Raised capital through a placement to fund further exploration activities
- Active management and review of the company's project portfolio
- Corporate updates include financial overview and strategic project focus
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westar Resources Limited (WSR) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Appendix 5B Cash Flow Report
|
30 Jul 2025 9:39AM |
$0.006 |
$0.007 |
risen by
16.67%
|
|
WSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report covers period ending 31 March 2023.
- Key exploration focus at Gidgee North Project, including Opaline Well and Mindoolah prospects.
- Completion of RC drilling and heritage survey at Opaline Well.
- Soil sampling, mapping, and geochemical targeting ongoing at Winjangoo and Birrigrin Projects.
- Strong cash position as reported in the Appendix 5B Cash Flow Report.
- Primary cash outflows directed to exploration and project development.
- No material changes to related party arrangements during the quarter.
- Company continues to comply with all listing and financial requirements.
- Westar Resources remains dedicated to advancing its portfolio of exploration projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
SPAC Veteran James Graf Joins Trigg to Lead US Listing
|
30 Jul 2025 9:39AM |
$0.085 |
$0.120 |
risen by
41.18%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$103 |
Update - Dividend/Distribution - LRT
|
30 Jul 2025 9:39AM |
$1.400 |
$2.470 |
risen by
76.43%
|
|
| Bass Oil Limited (BAS) ORDINARY FULLY PAID |
Energy |
$17 |
Quarterly Activities Report and Appendix 5B - June 2025
|
30 Jul 2025 9:39AM |
$0.026 |
$0.046 |
risen by
76.92%
|
|
BAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Steady production maintained from Indonesian oil assets during the quarter.
- New drilling and workover projects progressed to enhance production and reserves.
- Pursued strategic asset acquisitions and partnership opportunities.
- Financial results impacted by oil price volatility and ongoing cost management.
- Capital expenditure focused on field development and operational efficiency.
- Regulatory compliance and corporate governance updates provided.
- Continued community engagement and prioritization of health and safety.
- Exploration and development activities aimed at supporting future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investigator Silver Limited (IVR) ORDINARY FULLY PAID |
Materials |
$120 |
Quarterly Activities and Cash Flow Report
|
30 Jul 2025 9:38AM |
$0.026 |
$0.046 |
risen by
76.92%
|
|
IVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Cash Flow Report covers the period ending 31 March 2023.
- Main focus remains the Paris Silver Project in South Australia.
- Resource definition, technical studies, and exploration drilling preparation continued at Paris.
- Regional exploration included geological mapping and soil sampling at surrounding tenements.
- No mining production or development occurred during the quarter.
- Cash expenditure was primarily directed toward exploration activities.
- Closing cash balance reported at $10.5 million.
- Cash position considered adequate for upcoming planned work programs.
- No significant changes in tenement holdings or mining investments during the quarter.
- Ongoing community and environmental management commitments upheld.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CurveBeam AI Limited (CVB) ORDINARY FULLY PAID |
Health Care |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 9:38AM |
$0.078 |
$0.027 |
fallen by
65.38%
|
|
CVB - Price-sensitive ASX Announcement
Full Release
Key Points
- CurveBeam AI Limited (CVB) released its Appendix 4C Quarterly Cash Flow Report and provided an activities update for the quarter ended 31 March 2024.
- The company achieved a record quarterly revenue of A$3.2 million, an increase of 72% compared to the prior corresponding period.
- CVB reported cash receipts from customers of A$2.7 million for the quarter.
- The company launched its new HiRise product and delivered its first units as part of a limited market release.
- CurveBeam AI continued to progress its weight-bearing CT imaging and software solutions for orthopaedics and bone health.
- The company completed initial installations of its weight-bearing CT imaging units at key reference sites in the United States.
- CVB reported an operating cash outflow of A$0.6 million for the quarter, reflecting ongoing investment in product development and commercialization.
- Cash and cash equivalents at the end of the quarter were A$4.1 million.
- The company is focused on further expanding its US sales and marketing activities and scaling up production.
- CurveBeam AI expects to see continued growth in revenue and market adoption throughout the remainder of FY2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Garda Diversified Property Fund (GDF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$237 |
Garda Property Book
|
30 Jul 2025 9:38AM |
$1.270 |
$1.090 |
fallen by
14.17%
|
|
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:38AM |
$0.040 |
$0.024 |
fallen by
40%
|
|
KAL - Price-sensitive ASX Announcement
Full Release
Key Points
- New gold discovery at La Mascotte prospect within the Bulong Taurus Project.
- Drilling confirms high-grade gold mineralization and further drilling planned.
- Completion of an extensive soil geochemistry program at Pinjin and Zelica projects, identifying gold-in-soil anomalies.
- Strong commitment to ongoing exploration activities across KAL's portfolio.
- Prudent cash flow management and strong cash position maintained.
- Focus on value creation through discovery and exploration of new targets.
- Board and management actively monitoring opportunities to enhance shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$5,689 |
Update - Proposed issue of securities - RMS
|
30 Jul 2025 9:37AM |
$2.640 |
$3.000 |
risen by
13.64%
|
|
| Magnetite Mines Limited (MGT) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2025 9:37AM |
$0.085 |
$0.019 |
fallen by
77.65%
|
|
MGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Magnetite Mines Limited is advancing technical, engineering, and environmental studies for the Razorback Iron Ore Project.
- The company is actively engaging with government agencies for project approvals and permits.
- Discussions with potential offtake partners and financiers are ongoing to secure funding and sales agreements.
- Cost control and prudent cash management remain a priority for the company.
- The Appendix 5B cash flow statement details cash inflows, outflows, and the company's financial position at the end of the quarter.
- The report emphasizes the continued development and de-risking of the Razorback Iron Ore Project.
- No production or sales revenue recorded during the quarter; activities remain focused on project development.
- Exploration and evaluation expenditure was a significant component of quarterly cash outflow.
- The company held sufficient cash at the end of the quarter to continue planned activities.
- There were no related party payments other than standard remuneration to directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
